Diagnostics News and Research

RSS

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

GE Healthcare, a unit of General Electric Company, introduced today the new Invenia Automated Breast Ultrasound System at the 2013 Radiological Society of North America annual meeting.

2 Dec 2013

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.

28 Nov 2013

Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery

A protector for PTEN, a tumor-thwarting protein often missing in cancer cells, has emerged from research led by scientists at The University of Texas MD Anderson Cancer Center published online at Nature Cell Biology this week.

28 Nov 2013

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

People inherit different versions of any particular gene, and some genes affect how patients process and metabolize medicines. This especially holds true for people with cardiovascular (CV) disease. They may be fast, slow or non-metabolizers and might also react badly (with serious adverse events) to certain drug therapies or not at all.

27 Nov 2013

Study reveals how brain and olfactory system operate to process scent, odor signals

Our sense of smell is often the first response to environmental stimuli. Odors trigger neurons in the brain that alert us to take action.

27 Nov 2013

Thermo Fisher Scientific gets European Commission approval for Life Technologies deal

Thermo Fisher Scientific, the world leader in serving science, today announced that it has received approval from the European Commission for its pending acquisition of Life Technologies Corporation.

27 Nov 2013

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

27 Nov 2013

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Bruker Corporation today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens.

26 Nov 2013

Auditory processing disorder diagnosis: an interview with Dr Doris-Eva Bamiou, UCL Ear Institute

It is a listening or hearing disorder, which is due to the brain’s defective analysis of sounds, so that individuals who are affected with this disorder cannot make sense of what they hear.

26 Nov 2013

New concept outlines steps to tackle neglected tropical diseases, expedite poverty reduction efforts

A new concept and policy framework published in PLOS NTDs outlines concrete steps for the global development community as it works to synthesize health goals with economic, environmental and social priorities.

26 Nov 2013

Seed grants support cancer diagnosis and treatment, vascular health research

Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).

26 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

Hologic to highlight groundbreaking imaging products at RSNA 2013

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced the groundbreaking imaging products it will highlight at the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America at McCormick Place, Chicago from December 1st through 5th.

From Hologic, Inc. 21 Nov 2013

EKF Diagnostics introduces new version of Lactate Scout+ analyzer

EKF Diagnostics, the global diagnostics business, announces the launch of the new version of its Lactate Scout+ analyzer.

From EKF Diagnostics 20 Nov 2013

Parkinson's Institute, Population Diagnostics discover new genes relevant to Parkinson's disease

The Parkinson's Institute and Clinical Center announced today that they, in partnership with Population Diagnostics, Inc., have discovered a number of new genes relevant to the cause of Parkinson's disease.

20 Nov 2013

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.

20 Nov 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research.

18 Nov 2013

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

Eisai announces today that Halaven (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and NewBridge Pharmaceuticals.

18 Nov 2013

E-Rare funding recommended for European young investigators network for Usher syndrome

Based on a ranking list that was established by the EU Scientific Evaluation Committee, the E-Rare funding bodies recommended the European young investigators network for Usher syndrome coordinated by Dr. Kerstin Nagel-Wolfrum from Johannes Gutenberg University Mainz for funding. Out of 82 submitted projects, EUR-USH was among the 11 excellent scientific projects that were chosen after a competitive two-step scientific evaluation by peers. In October 2013, researchers held their kick-off meeting in Nijmegen, the Netherlands.

16 Nov 2013

Diagnostics News and Research

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

Study reveals how brain and olfactory system operate to process scent, odor signals

Thermo Fisher Scientific gets European Commission approval for Life Technologies deal

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Auditory processing disorder diagnosis: an interview with Dr Doris-Eva Bamiou, UCL Ear Institute

New concept outlines steps to tackle neglected tropical diseases, expedite poverty reduction efforts

Seed grants support cancer diagnosis and treatment, vascular health research

Researchers discover how type 2 diabetes drug metformin actually works

Hologic to highlight groundbreaking imaging products at RSNA 2013

EKF Diagnostics introduces new version of Lactate Scout+ analyzer

Parkinson's Institute, Population Diagnostics discover new genes relevant to Parkinson's disease

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

E-Rare funding recommended for European young investigators network for Usher syndrome

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News